drug targets

Faster drug discovery depends on both speed and data quality — a new mass spectrometry technology is helping researchers achieve both.

The drugmaker expands access to AI-driven discovery, but also positions its technology to become a standard across the sector.

A domain-specific AI platform enables scientists to generate and test hypotheses faster, helping pharma teams reduce target prioritization timelines from weeks to days.

From new biomarkers to smarter clinical trials, AI is transforming how cancer drugs are developed and how patients are diagnosed and treated.

Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program

Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.

An understudied melanoma arises without sun exposure, but researchers are beginning to shed light on this challenging form of skin cancer. 

Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.

Targeting a gut microbial enzyme could potentially improve treatment for type 2 diabetes.

The tumor microenvironment does more than simply support tumor growth. It may offer new avenues for cancer therapeutics.